Stoke Therapeutics (STOK) Announces CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Stoke Therapeutics Announces CEO Transition
March 18, 2025 6:58 AM EDTEdward M. Kaye, M.D., to Step Down as Chief Executive Officer
Director Ian F. Smith Appointed Interim Chief Executive Officer
Arthur Tzianabos Appointed Interim Executive Chairman of the Board
Board of Directors Initiates Search for Permanent Chief Executive Officer
BEDFORD, Mass.--(BUSINESS WIRE)--... More
